Stillen’s sales in December top 6.8 billion won

Published: 2009-01-29 06:58:00
Updated: 2009-01-29 06:58:00
Dong-A Pharma’s Stillen, Korea’s homegrown anti-ulcerant medicine, recorded 6.8 billion won in sales last December, a 31 percent jump from 2007, leading the domestic market, according to Ubist.

The market’s second player, Jeil Pharm, saw a 77.4 percent increase in last year’s December sales (3...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.